zinc phthalocyanine disulfonate

06/01/2007 - "Efficacy of ZnPcS2P2 photodynamic therapy solely or with tumor vaccines on mouse tumor models."
08/01/1993 - "Photodynamic therapy using the disulfonated zinc phthalocyanine did not induce vessel constriction or the release of eicosanoids, however, tumor cure was 43%. "
01/01/1997 - "The distribution study of zinc phthalocyanine disulfonate (ZnPcS2) in nude mice bearing mammary carcinoma (T50/80) revealed a rapid uptake of the dye by tumor. "
06/01/2007 - "In this preliminary study, we evaluated the photodynamic efficacy of ZnPcS2P2 on two tumor models and the improving anti-tumor efficacy of PDT in combination with GM-CSF gene-transduced vaccine and B7.1 gene-transduced vaccine. "
11/01/2004 - "The di-sulfonated di-phthalimidomethyl phthalocyanine zinc (ZnPcS2P2) was an amphiphilic photosensitizer for photodynamic therapy of cancer. "

06/01/2007 - "Nude mice bearing human leukemia xenograft and C57BL/6 mice bearing EL-4 thymic lymphoma were used to evaluate photodynamic efficacy of ZnPcS2P2. "

06/01/2007 - "Nude mice bearing human leukemia xenograft and C57BL/6 mice bearing EL-4 thymic lymphoma were used to evaluate photodynamic efficacy of ZnPcS2P2. "

01/01/1997 - "Distribution and photodynamic effect of zinc phthalocyanine disulfonate in nude mice bearing mammary carcinoma."
01/01/1997 - "The distribution study of zinc phthalocyanine disulfonate (ZnPcS2) in nude mice bearing mammary carcinoma (T50/80) revealed a rapid uptake of the dye by tumor. "

09/01/2005 - "To investigate the mechanism underlying the killing effects of a novel amphipathic photosensitizer, disulfonated diphthalimidomethyl phthalocyanine zinc (ZnPcS2P2), mediated photodynamic therapy (ZnPc-PDT) in human myelogenous leukemia HL60 cells. "